M. Biostatistics and . Paristech, 5 Genetic oncology service, Institut Curie, rue d'Ulm 26, Paris cedex 05 Villeurbanne cedex Villeurbanne cedex, 69622, France. 8 Unit of genetic epidemiology and prevention, Centre Léon Bérard, rue Laennec 28, Lyon cedex 08, 69373, France. 9 Unit of oncology, Centre Paul Strauss, rue de la porte de l'Hôpital 3 10 Unit of oncology 13 Unit of gynecological pathology 15 Medical genetics, Hôpital d'enfants, boulevard Maréchal de Lattre de Tassigny 10 16 Unit medical genetics and oncology Unit of medical oncology, Oncology center for the regional cancer genetics consultation Poitou-Charentes, pp.18-20, 2019.

N. Authors-'contributions and C. , CN was responsible for the coordination of the study. RL supervised the mutation codification. GENEPSO group members made a major contribution to acquisition of data. JL was responsible for data preparation, conducted the statistical analyses andwrote the manuscript. NA supervised the analyses and participated in writing of the manuscript. All authors contributed to the interpretation and discussion of the findings and revised the manuscript critically and have given final approval of the version to be published

. Authors-'information, . Genepso-collaborating, and . Centers, Coordinating Center, Hôpital René Huguenin/Institut Curie, Saint Cloud: Catherine Noguès, Emmanuelle Fourme, Institut Curie

M. Gauthier, -. Buecher, and I. G. Roussy, Olivier Caron; Hôpital René Huguenin/Institut Curie, Saint Cloud: Catherine Noguès, Liliane Demange

. Centre-léon and . Bérard, Valérie Bonadona; Centre François Baclesse, Caen: Pascaline Berthet; Hôpital d'Enfants CHU Dijon -Centre Georges François Leclerc, Dijon: Laurence Faivre

J. Gh-pitié-salpétrière-annick-rossi and . Tinat, Reims: Tan Dat Nguyen; Centre René Gauducheau, Nantes: Capucine Delnatte Isabelle Tennevet; Hôpital Civil Clermont-Ferrand: Yves-Jean Bignon; Polyclinique Courlancy, Reims: Liliane Demange; Clinique Sainte Catherine, Avignon: Hélène Dreyfus; Hôpital Saint-Louis

A. Antoniou, P. Pharoah, S. Narod, H. Risch, J. Eyfjord et al., Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies, The American Journal of Human Genetics, vol.72, issue.5, pp.1117-1130, 2003.
DOI : 10.1086/375033

P. Parsa and B. Parsa, Effects of reproductive factors on risk of breast cancer: a literature review, Asian Pac J Cancer Prev, vol.10, pp.545-550, 2009.

N. Breast, . Ovarian-cancer, and . Centre, Breast cancer risk factors, a review of the evidence Australian Government, Cancer Australia/view-document-details/rfrw-breast- cancer-risk-factors-a-review-of-the-evidence, 2009.

P. Newcomb, B. Storer, M. Longnecker, R. Mittendorf, E. Greenberg et al., Pregnancy Termination in Relation to Risk of Breast Cancer, JAMA: The Journal of the American Medical Association, vol.275, issue.4, pp.283-287, 1996.
DOI : 10.1001/jama.1996.03530280035033

J. Brind, V. Chinchilli, W. Severs, and J. Summy-long, Induced abortion as an independent risk factor for breast cancer: a comprehensive review and meta-analysis., Journal of Epidemiology & Community Health, vol.50, issue.5, pp.481-496, 1996.
DOI : 10.1136/jech.50.5.481

P. Wingo, K. Newsome, J. Marks, E. Calle, and S. Parker, The risk of breast cancer following spontaneous or induced abortion, Cancer Causes and Control, vol.8, issue.1, pp.93-108, 1997.
DOI : 10.1023/A:1018443507512

G. Zografos, M. Panou, and N. Panou, Common risk factors of breast and ovarian cancer: recent view, International Journal of Gynecological Cancer, vol.14, issue.5, pp.721-740, 2004.
DOI : 10.1111/j.1048-891X.2004.14503.x

J. Daling, L. Brinton, L. Voigt, N. Weiss, R. Coates et al., Risk of Breast Cancer among White Women following Induced Abortion, American Journal of Epidemiology, vol.144, issue.4, pp.373-380, 1996.
DOI : 10.1093/oxfordjournals.aje.a008938

V. Beral, D. Bull, R. Doll, R. Peto, and G. Reeves, Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83 000 women with breast cancer from 16 countries, Lancet, vol.363, pp.1007-1016, 2004.

J. Palmer, L. Wise, L. Adams-campbell, and L. Rosenberg, A prospective study of induced abortion and breast cancer in African-American women, Cancer Causes & Control, vol.15, issue.2, pp.105-111, 2004.
DOI : 10.1023/B:CACO.0000019484.29558.f7

M. Mahue-giangreco, G. Ursin, J. Sullivan-halley, and L. Bernstein, Induced abortion, miscarriage, and breast cancer risk of young women, Cancer Epidemiol Biomarkers Prev, vol.12, pp.209-214, 2003.

E. Friedman, J. Kotsopoulos, J. Lubinski, H. Lynch, P. Ghadirian et al., Spontaneous and therapeutic abortions and the risk of breast cancer among BRCAmutation carriers, Breast Cancer Research, vol.117, issue.21, p.15, 2006.
DOI : 10.1002/ijc.21273

H. Jernstrom, C. Lerman, P. Ghadirian, H. Lynch, B. Weber et al., Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2, The Lancet, vol.354, issue.9193, pp.1846-1850, 1999.
DOI : 10.1016/S0140-6736(99)04336-6

L. Tryggvadottir, E. Olafsdottir, S. Gudlaugsdottir, S. Thorlacius, J. Jonasson et al., BRCA2mutation carriers, reproductive factors and breast cancer risk, Breast Cancer Research, vol.154, issue.5, pp.121-128, 2003.
DOI : 10.1093/aje/154.8.687

E. Lee, H. Ma, R. Mckean-cowdin, B. Van-den, L. Bernstein et al., Effect of Reproductive Factors and Oral Contraceptives on Breast Cancer Risk in BRCA1/2 Mutation Carriers and Noncarriers: Results from a Population-Based Study, Cancer Epidemiology Biomarkers & Prevention, vol.17, issue.11, pp.3170-3178, 2008.
DOI : 10.1158/1055-9965.EPI-08-0396

H. Jernstrom, J. Lubinski, H. Lynch, P. Ghadirian, S. Neuhausen et al., Breast-feeding and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers, JNCI Journal of the National Cancer Institute, vol.96, issue.14, pp.1094-1098, 2004.
DOI : 10.1093/jnci/djh211

J. Kotsopoulos, J. Lubinski, H. Lynch, J. Klijn, P. Ghadirian et al., Age at first birth and the risk of breast cancer Lecarpentier et al. Breast Cancer Research, Breast Cancer Res Treat, vol.14, issue.105, pp.99-221, 2007.

P. Hartge, N. Chatterjee, S. Wacholder, L. Brody, M. Tucker et al., Breast Cancer Risk in Ashkenazi BRCA1/2 Mutation Carriers: Effects of Reproductive History, Epidemiology, vol.13, issue.3, pp.255-261, 2002.
DOI : 10.1097/00001648-200205000-00004

T. Rebbeck, Y. Wang, P. Kantoff, K. Krithivas, S. Neuhausen et al., Modification of BRCA1-and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history, Cancer Res, vol.61, pp.5420-5424, 2001.

R. Milne, A. Osorio, T. Cajal, M. Baiget, A. Lasa et al., Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers, Breast Cancer Research and Treatment, vol.55, issue.3, pp.221-232, 2010.
DOI : 10.1007/s10549-009-0394-1

C. Cullinane, J. Lubinski, S. Neuhausen, P. Ghadirian, H. Lynch et al., Effect of pregnancy as a risk factor for breast cancer inBRCA1/BRCA2 mutation carriers, International Journal of Cancer, vol.96, issue.6, pp.988-991, 2005.
DOI : 10.1002/ijc.21273

J. Russo and I. Russo, Development of the human breast, Maturitas, vol.49, issue.1, pp.2-15, 2004.
DOI : 10.1016/j.maturitas.2004.04.011

J. Russo and I. Russo, Cellular basis of breast cancer susceptibility, Oncol Res, vol.11, pp.169-178, 1999.

S. Gayther, J. Mangion, P. Russell, S. Seal, R. Barfoot et al., Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene, Nature Genetics, vol.3, issue.1, pp.103-105, 1997.
DOI : 10.1016/0092-8674(93)90538-2

D. Thompson and D. Easton, Variation in Cancer Risks, by Mutation Position, in BRCA2 Mutation Carriers, The American Journal of Human Genetics, vol.68, issue.2, pp.410-419, 2001.
DOI : 10.1086/318181

D. Thompson and D. Easton, Variation in BRCA1 cancer risks by mutation position, Cancer Epidemiol Biomarkers Prev, vol.11, pp.329-336, 2002.

J. Lubinski, C. Phelan, P. Ghadirian, H. Lynch, J. Garber et al., Cancer variation associated with the position of the mutation in the BRCA2 gene, Familial Cancer, vol.3, issue.1, pp.1-10, 2004.
DOI : 10.1023/B:FAME.0000026816.32400.45

J. Lecarpentier, C. Nogues, E. Mouret-fourme, D. Stoppa-lyonnet, C. Lasset et al., Variation in breast cancer risk with mutation position, smoking, alcohol, and chest X-ray history, in the French National BRCA1/2 carrier cohort (GENEPSO), the French National BRCA1/2 carrier cohort (GENEPSO), pp.927-938, 2011.
DOI : 10.1007/s10549-011-1655-3
URL : https://hal.archives-ouvertes.fr/hal-00698006

H. Risch, J. Mclaughlin, D. Cole, B. Rosen, L. Bradley et al., Prevalence and Penetrance of Germline BRCA1 and BRCA2 Mutations in a Population Series of 649 Women with Ovarian Cancer, The American Journal of Human Genetics, vol.68, issue.3, pp.700-710, 2001.
DOI : 10.1086/318787

H. Risch, J. Mclaughlin, D. Cole, B. Rosen, L. Bradley et al., Population BRCA1 and BRCA2 Mutation Frequencies and Cancer Penetrances: A Kin-Cohort Study in Ontario, Canada, JNCI Journal of the National Cancer Institute, vol.98, issue.23, pp.1694-1706, 2006.
DOI : 10.1093/jnci/djj465

D. Evans, A. Shenton, E. Woodward, F. Lalloo, A. Howell et al., Penetrance estimates for BRCA1 and BRCA2based on genetic testing in a Clinical Cancer Genetics service setting: Risks of breast/ovarian cancer quoted should reflect the cancer burden in the family, BMC Cancer, vol.8, issue.1, p.155, 2008.
DOI : 10.1186/bcr1365

C. Begg, R. Haile, A. Borg, K. Malone, P. Concannon et al., Variation of Breast Cancer Risk Among BRCA1/2 Carriers, JAMA, vol.299, issue.2, pp.194-201, 2008.
DOI : 10.1001/jama.2007.55-a

J. Schouten, C. Mcelgunn, R. Waaijer, D. Zwijnenburg, F. Diepvens et al., Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification, Nucleic Acids Research, vol.30, issue.12, p.57, 2002.
DOI : 10.1093/nar/gnf056

F. Casilli, D. Rocco, Z. Gad, S. Tournier, I. Stoppa-lyonnet et al., Rapid detection of novelBRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments, Human Mutation, vol.33, issue.3, pp.218-226, 2002.
DOI : 10.1002/humu.10108

M. Barrois, I. Bieche, S. Mazoyer, M. Champeme, B. Bressac-de-paillerets et al., Real-time PCR-based gene dosage assay for detecting BRCA1 rearrangements in breast-ovarian cancer families, Clinical Genetics, vol.39, issue.2, pp.131-136, 2004.
DOI : 10.1111/j.0009-9163.2004.00200.x

E. Rouleau, C. Lefol, V. Bourdon, F. Coulet, T. Noguchi et al., germline mutations in Lynch syndrome, Human Mutation, vol.56, issue.6, pp.867-875, 2009.
DOI : 10.1002/humu.20947

J. Weber, S. Miserere, J. Champ, R. Looten, D. Stoppa-lyonnet et al., High-throughput simultaneous detection of point mutations and large-scale rearrangements by CE, ELECTROPHORESIS, vol.24, issue.23, pp.4282-4288, 2007.
DOI : 10.1002/elps.200700010

S. Gad, A. Aurias, N. Puget, A. Mairal, C. Schurra et al., Color bar coding theBRCA1 gene on combed DNA: A useful strategy for detecting large gene rearrangements, Genes, Chromosomes and Cancer, vol.6, issue.1, pp.75-84, 2001.
DOI : 10.1002/gcc.1120

E. Rouleau, C. Lefol, S. Tozlu, C. Andrieu, C. Guy et al., High-resolution oligonucleotide array-CGH applied to the detection and characterization of large rearrangements in the hereditary breast cancer gene BRCA1, Clinical Genetics, vol.73, issue.6, pp.199-207, 2007.
DOI : 10.1111/j.1399-0004.2007.00849.x

A. Antoniou, D. Goldgar, N. Andrieu, J. Chang-claude, R. Brohet et al., A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes, Genetic Epidemiology, vol.10, issue.1, pp.1-11, 2005.
DOI : 10.1002/gepi.20074

E. Negri, L. Vecchia, C. Bruzzi, P. Dardanoni, G. Decarli et al., RISK FACTORS FOR BREAST CANCER: POOLED RESULTS FROM THREE ITALIAN CASE-CONTROL STUDIES, American Journal of Epidemiology, vol.128, issue.6, pp.1207-1215, 1988.
DOI : 10.1093/oxfordjournals.aje.a115075

J. Kelsey, M. Gammon, and E. John, Reproductive Factors and Breast Cancer, Epidemiologic Reviews, vol.15, issue.1, pp.36-47, 1993.
DOI : 10.1093/oxfordjournals.epirev.a036115

V. Beral and G. Reeves, Childbearing, oral contraceptive use, and breast cancer, The Lancet, vol.341, issue.8852, p.1102, 1993.
DOI : 10.1016/0140-6736(93)92469-A

M. Lambe, C. Hsieh, D. Trichopoulos, A. Ekbom, M. Pavia et al., Transient Increase in the Risk of Breast Cancer after Giving Birth, New England Journal of Medicine, vol.331, issue.1, pp.5-9, 1994.
DOI : 10.1056/NEJM199407073310102

A. Antoniou, A. Shenton, E. Maher, E. Watson, E. Woodward et al., Parity and breast cancer risk among BRCA1 and BRCA2mutation carriers, Breast Cancer Research, vol.66, issue.6, p.72, 2006.
DOI : 10.1158/0008-5472.CAN-05-3368

J. Daling, K. Malone, L. Voigt, E. White, and N. Weiss, Risk of Breast Cancer Among Young Women: Relationship to Induced Abortion, JNCI Journal of the National Cancer Institute, vol.86, issue.21, pp.1584-1592, 1994.
DOI : 10.1093/jnci/86.21.1584

N. Andrieu, S. Duffy, T. Rohan, M. Le, E. Luporsi et al., Familial risk, abortion and their interactive effect on the risk of breast cancer - a combined analysis of six case-control studies, British Journal of Cancer, vol.72, issue.3, pp.744-751, 1995.
DOI : 10.1038/bjc.1995.404

M. Rookus and F. Van-leeuwen, Induced Abortion and Risk for Breast Cancer: Reporting (Recall) Bias in a Dutch Case-Control Study, JNCI Journal of the National Cancer Institute, vol.88, issue.23, pp.1759-1764, 1996.
DOI : 10.1093/jnci/88.23.1759

J. Russo, L. Tay, and I. Russo, Differentiation of the mammary gland and susceptibility to carcinogenesis, Breast Cancer Research and Treatment, vol.8, issue.Suppl, pp.5-73, 1982.
DOI : 10.1007/BF01805718

L. Vatten, P. Romundstad, D. Trichopoulos, and R. Skjaerven, Pregnancy related protection against breast cancer depends on length of gestation, British Journal of Cancer, vol.87, issue.3, pp.289-290, 2002.
DOI : 10.1038/sj.bjc.6600453

S. Fan, Y. Ma, C. Wang, R. Yuan, Q. Meng et al., Role of direct interaction in BRCA1 inhibition of estrogen receptor activity, Oncogene, vol.20, issue.1, pp.77-87, 2001.
DOI : 10.1038/sj.onc.1204073

M. Razandi, A. Pedram, E. Rosen, and E. Levin, BRCA1 Inhibits Membrane Estrogen and Growth Factor Receptor Signaling to Cell Proliferation in Breast Cancer, Molecular and Cellular Biology, vol.24, issue.13, pp.5900-5913, 2004.
DOI : 10.1128/MCB.24.13.5900-5913.2004

A. Cabanes, M. Wang, S. Olivo, S. Deassis, J. Gustafsson et al., Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis, Carcinogenesis, vol.25, issue.5, pp.741-748, 2004.
DOI : 10.1093/carcin/bgh065
URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.535.4858

H. Ma, Y. Wang, J. Sullivan-halley, L. Weiss, P. Marchbanks et al., Use of Four Biomarkers to Evaluate the Risk of Breast Cancer Subtypes in the Women's Contraceptive and Reproductive Experiences Study, Cancer Research, vol.70, issue.2, pp.575-587, 2010.
DOI : 10.1158/0008-5472.CAN-09-3460